H35.179 Retrolental fibroplasia, unspecified eye

Name of the Condition

• Retrolental fibroplasia, unspecified eye

Summary

Retrolental fibroplasia, unspecified eye is a condition characterized by abnormal fibrous tissue growth behind the lens of the eye, often associated with retinopathy of prematurity. This can lead to visual impairment or blindness if untreated. The condition primarily affects premature infants, with severity varying based on gestational age and other factors.

Causes

Retrolental fibroplasia is caused by abnormal retinal vascular development in premature infants. The retina, which normally completes vascularization by full-term birth, may not fully develop in preterm infants. Factors such as oxygen therapy, fluctuations in oxygen levels, and the infant's overall immaturity contribute to abnormal tissue growth behind the lens.

Risk Factors

• Prematurity (especially infants born before 31 weeks of gestation).
• Low birth weight (typically under 1500 grams).
• Oxygen therapy or fluctuations in oxygen levels during neonatal care.
• Multiple births (e.g., twins or triplets).
• Certain medical conditions affecting oxygen delivery or retinal development.

Symptoms

In early stages, retrolental fibroplasia may not present obvious symptoms. Severe cases can lead to abnormal eye movements, a white appearance of the pupil (leukocoria), or vision impairment as the child grows. Infants with this condition are typically asymptomatic initially.

Diagnosis

Diagnosis involves a comprehensive eye examination, including ophthalmoscopy to assess retinal blood vessels and fibrous tissue growth. Imaging studies or specialized tests may be used to evaluate the extent of the condition. Clinical history, including prematurity and oxygen exposure, is also considered.

Treatment Options

Treatment depends on severity and may include monitoring for mild cases, laser therapy or cryotherapy to reduce abnormal blood vessel growth, or surgical intervention for advanced stages. Early detection and intervention are critical to preserving vision.

Prognosis and Follow-Up

Prognosis varies based on the stage at diagnosis and response to treatment. Regular follow-up with an ophthalmologist is essential to monitor for progression or complications. Long-term vision outcomes range from normal to severe impairment, depending on the severity of the condition.

Complications

Potential complications include retinal detachment, glaucoma, strabismus, amblyopia, or permanent vision loss. Severe cases may lead to blindness if not managed appropriately.

Lifestyle & Prevention

Preventive measures focus on careful oxygen management in premature infants to reduce the risk of retinopathy of prematurity. Regular eye screenings for at-risk infants are recommended to detect and address issues early.

When to Seek Professional Help

Seek immediate medical attention if symptoms such as leukocoria, abnormal eye movements, or vision changes are observed in an infant or child. Early evaluation by an ophthalmologist is crucial for timely intervention.

Tips for Medical Coders

Use H35.179 for retrolental fibroplasia when the eye is unspecified. Document whether the condition is unilateral or bilateral, as this may impact coding specificity. Ensure clinical documentation supports the diagnosis and any associated factors, such as prematurity or oxygen therapy, to justify code assignment.